Quantitation of secretory group V phospholipase A2 in human tissues by sandwich enzyme-linked immunosorbent assay

Nilda M Muñoz,Evan Boetticher,Anne I Sperling,Kwang-Pyo Kim,Angelo Y Meliton,Xiangdong Zhu,Anissa Lambertino,Wonhwa Cho,Alan R Leff
DOI: https://doi.org/10.1016/S0022-1759(01)00573-7
IF: 2.287
2002-01-01
Journal of Immunological Methods
Abstract:We have developed a sensitive sandwich ELISA (sELISA) for quantitative determination of group V phospholipase A2 (gVPLA2). This assay utilizes three monoclonal antibodies (mAbs) directed against human gVPLA2 (MCL-1B7, MCL-2A5, and MCL-3G1), which recognize specifically different epitopes of gVPLA2. A mixture of MCL-1B7 and MCL-2A5 was used as the capture mAb, and MCL-3G1 as the detector mAb; purified human gVPLA2 was used as the standard protein. The limit of detection of the sELISA is 2 ng/ml; the intra- and inter-coefficients of variation were 4.97±0.81% and 8.42±3.4%. The validity of the sELISA was assured by the recovery of exogenous recombinant gVPLA2, which was 99.7% to 102%, and demonstration of noninterference of the gVPLA2 assay by a high concentrations of other protein from murine lung and heart. To assess the usefulness of this sELISA for tissue measurements, the amount of gVPLA2 in cultured human epithelial cells and isolated human eosinophils was determined. Total gVPLA2 mass in epithelial cells was 2.83±0.33 ng/107 cells; gVPLA2 was not detected in eosinophils. The presence of high concentration of gVPLA2 in epithelial cells was confirmed by immunoprecipitation/Western blot analysis and by flow cytometry. This assay allows for convenient differentiation between the highly homologous 14-kDa secretory PLA2s, gVPLA2, gIIaPLA2, gIbPLA2 and gXPLA2, and accurate quantitation of gVPLA2 in biological samples.
What problem does this paper attempt to address?